These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 24839953

  • 1. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC, Chao YJ, Tung HL, Wang HC, Shan YS.
    Cancer; 2014 Sep 01; 120(17):2766-77. PubMed ID: 24839953
    [Abstract] [Full Text] [Related]

  • 2. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.
    Kim HS, Yoo SY, Kim KT, Park JT, Kim HJ, Kim JC.
    Int J Clin Exp Pathol; 2012 Sep 01; 5(8):754-61. PubMed ID: 23071857
    [Abstract] [Full Text] [Related]

  • 3. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S, Matsuda Y, Hagio M, Ueda J, Naito Z, Ishiwata T.
    Int J Oncol; 2012 Oct 01; 41(4):1314-24. PubMed ID: 22824809
    [Abstract] [Full Text] [Related]

  • 4. Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers.
    Immervoll H, Hoem D, Steffensen OJ, Miletic H, Molven A.
    J Histochem Cytochem; 2011 Apr 01; 59(4):441-55. PubMed ID: 21411814
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N.
    Oncol Rep; 2012 Oct 01; 28(4):1301-8. PubMed ID: 22895640
    [Abstract] [Full Text] [Related]

  • 6. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z, Maeda D, Yoshida M, Umakoshi M, Nanjo H, Shiraishi K, Saito M, Kohno T, Konno H, Saito H, Minamiya Y, Goto A.
    Lung Cancer; 2018 Sep 01; 123():127-135. PubMed ID: 30089583
    [Abstract] [Full Text] [Related]

  • 7. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y, Sakamoto N, Oo HZ, Naito Y, Uraoka N, Anami K, Sentani K, Oue N, Yasui W.
    Pathol Int; 2012 Feb 01; 62(2):112-9. PubMed ID: 22243781
    [Abstract] [Full Text] [Related]

  • 8. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
    Durko L, Wlodarski W, Stasikowska-Kanicka O, Wagrowska-Danilewicz M, Danilewicz M, Hogendorf P, Strzelczyk J, Malecka-Panas E.
    Dis Markers; 2017 Feb 01; 2017():3276806. PubMed ID: 28659655
    [Abstract] [Full Text] [Related]

  • 9. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA, Fawzy M, El-Wakil M, Zekri AR, Abdel-Sayed A, Sheta M.
    Transl Res; 2015 Mar 01; 165(3):396-406. PubMed ID: 25168019
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
    Pitule P, Cedikova M, Daum O, Vojtisek J, Vycital O, Hosek P, Treska V, Hes O, Kralickova M, Liska V.
    Biomed Res Int; 2014 Mar 01; 2014():432139. PubMed ID: 24864242
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis.
    Li X, Zhao H, Gu J, Zheng L.
    Int J Clin Exp Pathol; 2015 Mar 01; 8(10):12084-92. PubMed ID: 26722393
    [Abstract] [Full Text] [Related]

  • 12. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
    Yao J, An Y, Wie JS, Ji ZL, Lu ZP, Wu JL, Jiang KR, Chen P, Xu ZK, Miao Y.
    Swiss Med Wkly; 2011 Mar 01; 141():w13208. PubMed ID: 21630164
    [Abstract] [Full Text] [Related]

  • 13. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
    Zhang Y, Wei J, Wang H, Xue X, An Y, Tang D, Yuan Z, Wang F, Wu J, Zhang J, Miao Y.
    Oncol Rep; 2012 May 01; 27(5):1599-605. PubMed ID: 22322379
    [Abstract] [Full Text] [Related]

  • 14. Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma.
    Xue Z, Zhou Y, Wang C, Zheng J, Zhang P, Zhou L, Wu L, Shan Y, Ye M, He Y, Cai Z.
    Oncol Rep; 2016 Jan 01; 35(1):50-8. PubMed ID: 26530530
    [Abstract] [Full Text] [Related]

  • 15. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE.
    PLoS One; 2011 Jan 01; 6(6):e20636. PubMed ID: 21695188
    [Abstract] [Full Text] [Related]

  • 16. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
    Zhang Y, Sun B, Zhao X, Liu Z, Wang X, Yao X, Dong X, Chi J.
    J Surg Oncol; 2013 Nov 01; 108(6):414-9. PubMed ID: 23996537
    [Abstract] [Full Text] [Related]

  • 17. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.
    Poruk KE, Blackford AL, Weiss MJ, Cameron JL, He J, Goggins M, Rasheed ZA, Wolfgang CL, Wood LD.
    Clin Cancer Res; 2017 Jun 01; 23(11):2681-2690. PubMed ID: 27789528
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
    Hang D, Dong HC, Ning T, Dong B, Hou DL, Xu WG.
    Dis Esophagus; 2012 Jun 01; 25(7):638-44. PubMed ID: 22236447
    [Abstract] [Full Text] [Related]

  • 19. Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.
    Nomura A, McGinn O, Dudeja V, Sangwan V, Saluja AK, Banerjee S.
    Mol Cancer; 2015 Nov 23; 14():200. PubMed ID: 26597727
    [Abstract] [Full Text] [Related]

  • 20. [Expressions of CD133 and CD44 in gastric adenocarcinoma and their relationship with E-cadherin expression].
    Lu G, Wu X, Zhou L, Yu L, Wu S.
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov 23; 33(11):1632-7. PubMed ID: 24273267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.